AP via Canadian Business | Drug and medical product developer Abbott Laboratories said Thursday its
$450 million buyout of Facet Biotech Corp. has passed an antitrust
regulatory waiting period.
Get the full story: canadianbusiness.com.
Filed under Pharmaceuticals
Abbott buyout of Facet passes US antitrust period
Posted April 8, 2010 at 11:51 a.m.
